RVTY

NYSE Revvity, Inc.
Oct 19, 2026 · 11:33 PM ET EOD Market Closed

$150.94 ↑ +0.00 (+0.00%) Trading Up from the previous close of $150.94, $5.93 below the day’s high of $156.87

YTD change
+56.01%
vs 20-day SMA
-0.33%
vs 200-day SMA
+38.33%

Price ranges

Previous day
$151.61 $155.50
open $154.44 close $152.64
-$1.80 (-1.17%)
Today
$150.71 $156.87
open $153.89 now $150.94
-$2.95 (-1.92%)
Past week
$148.83 $158.00
from $154.18 now $150.94
-$3.24 (-2.10%)
Past month
$140.08 $166.25
from $143.45 now $150.94
+$7.49 (+5.22%)
This year
$81.22 $166.25
from $96.75 now $150.94
+$54.19 (+56.01%)

Price & Performance

+57.91 (+62.25%) / 6M

$76.25$105.29$134.33$163.37Apr 20Jul 21Oct 19

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 9.2% away from all-time highs of $166.25
  • RVTY is up 56% since the beginning of the year
  • RVTY is up 62% over the past 12 months
  • RVTY is up 5% over the past 1 month
  • 6% of all RVTY investors are betting against RVTY
  • Number of investors short RVTY has gone down 0% versus last month

RVTY reads neutral: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is +58.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $1.41
Earnings momentum -8.8% Quarterly EPS growth
Quarterly change -8.8%

Valuation

P/E ratio 74.02
Enterprise value $19.4B
Beta 1.09

Balance sheet & scale

Income$237.4K
Revenue$2.9B
Cash$1.0B
Debt$3.3M
Income / Debt 0.07×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Manufacturing
Sub Sector Computer and Electronic Product Manufacturing
Market cap $16.8B

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.

Competitor comparison

TickerCompany PriceChange
A Agilent Technologies, Inc. $169.90 -1.77%
WAT Waters Corporation $434.27 -0.61%
ILMN Illumina, Inc. $262.66 +0.05%
MTD Mettler-Toledo International Inc. $1,625.73 +0.21%
SOAGY Sartorius AG Unsponsored ADR Pfd $58.21 -0.22%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.